Loading...

PTC Therapeutics, Inc.

PTCT•NASDAQ
Healthcare
Biotechnology
$68.23
$-0.36(-0.52%)
U.S. Market opens in 49h 27m

PTC Therapeutics, Inc. (PTCT) Stock Overview

Explore PTC Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.6B
P/E Ratio8.07
EPS (TTM)$8.58
ROE-3.62%
Fundamental Analysis

AI Price Forecasts

1 Month$72.78
3 Months$76.86
1 Year Target$86.77

PTCT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PTC Therapeutics, Inc. (PTCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $86.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.07 and a market capitalization of 5.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.52%
5-Day Change
-6.98%
1-Month Change
5.72%
3-Month Change
-9.33%
6-Month Change
2.76%
Year-to-Date (YTD) Change
-10.18%
1-Year Change
37.70%
3-Year Change
29.10%
5-Year Change
46.42%
All-Time (Max) Change
313.77%

Contact Information

https://www.ptcbio.com
908 222 7000
100 Corporate Court, Warren, NJ, 07080

Company Facts

939 Employees
IPO DateJun 20, 2013
CountryUS
Actively Trading

Frequently Asked Questions